J. Portu

Treatment of chronic he1patitis C genotype 1 with peginterferon‐ α2a (40 kDa) plus ribavirin under routine clinical practice in Spain: early prediction of sustained virological response rate

M. Roset, B. Dalmau, M. Diago, 2007, Alimentary pharmacology & therapeutics.

Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.

J. Benito, V. Soriano, J. Pineda, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.